Meena Bolourchi

Dr. Meena Bolourchi

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in The American Journal of Cardiology
Verified
Journal Article
Closed access
MBMeena Bolourchi
Meena Bolourchi
ESEric S. Silver
Eric S. Silver
DMDavid Muwanga
David Muwanga
EMEsteban Mendez
Esteban Mendez
LLLeonardo Liberman
Leonardo Liberman

1 March 2015 in The American Journal of Cardiology
Verified
Journal Article
Closed access
MBMeena Bolourchi
Meena Bolourchi
ABAnjan S. Batra
Anjan S. Batra

Verified
Journal Article
Open access
PDF file
MBMeena Bolourchi
Meena Bolourchi
PRPierangelo Renella
Pierangelo Renella
RWRaymond Wang
Raymond Wang
The prevalence of aortic root dilatation (ARD) in mucopolysaccharidosis (MPS) is not well documented. We investigated aortic root measurements in 34 MPS patients at the Children’s Hospital of Orange County (CHOC). The diagnosis, treatment status, age, gender, height, weight and aortic root parameters (aortic valve annulus (AVA), sinuses of Valsalva (SoV), and sinotubular junction (STJ)) were extracted by retrospective chart review and echocardiographic measurements. Descriptive statistics, ANOVA, and paired post-hoc t-tests were used to summarize the aortic dimensions. Exact binomial 95% confidence intervals (CIs) were constructed for ARD, defined as a z-score greater than 2 at the SoV. The patient age ranged from 3.4–25.9 years (mean 13.3 ± 6.1), the height from 0.87–1.62 meters (mean 1.24 ± 0.21), and the weight from 14.1–84.5 kg (mean 34.4 ± 18.0). The prevalence of dilation at the AVA was 41% (14/34; 95% CI: 25%–59%); at the SoV was 35% (12/34; 95% CI: 20%–54%); and at the STJ was 30% (9/30; 95% CI: 15%–49%). The highest prevalence of ARD was in MPS IVa (87.5%). There was no significant difference between mean z-scores of MPS patients who received treatment with hematopoietic stem cell transplantation (HSCT) or enzyme replacement therapy (ERT) vs. untreated MPS patients at the AVA (z = 1.9 ± 2.5 vs. z = 1.5 ± 2.4; p = 0.62), SoV (z = 1.2 ± 1.6 vs. z = 1.3 ± 2.2; p = 0.79), or STJ (z = 1.0 ± 1.8 vs. z = 1.2 ± 1.6; p = 0.83). The prevalence of ARD was 35% in our cohort of MPS I–VII patients. Thus, we recommend screening for ARD on a routine basis in this patient population.

1 January 2012 in Journal of Surgical Education
Verified
Journal Article
Closed access
CLCatherine A. Logan
Catherine A. Logan
BCBrienne D. Cressey
Brienne D. Cressey
RWRoger Y. Wu
Roger Y. Wu
AJAdam J. Janicki
Adam J. Janicki
CCCyril X. Chen
Cyril X. Chen
DFDavid G. Fairchild
David G. Fairchild

31 October 2018 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
MBMeena Bolourchi
Meena Bolourchi
ESEric S. Silver
Eric S. Silver
LLLeonardo Liberman
Leonardo Liberman

26 December 2018 in Pediatric Emergency Care
Verified
Journal Article
Closed access
MBMeena Bolourchi
Meena Bolourchi
PRPooja Renjen
Pooja Renjen
AKArzu Kovanlikaya
Arzu Kovanlikaya
MBMichael Baad
Michael Baad
MTMichael Traister
Michael Traister
JKJeffrey H. Kern
Jeffrey H. Kern
Epipericardial fat necrosis is a rare cause of acute pleuritic chest pain reported in approximately 40 cases. This diagnosis mimics a myocardial infarction, pulmonary embolism, or pericarditis; however, the cardiac enzymes and electrocardiogram are usually normal. We present the first reported case of epipericardial fat necrosis in an adolescent.